We recently reported that in addition to its classical cytoplasmic location, the fast skeletal muscle Troponin T3 (TnT3) shuttles to the nucleus, where it appears to perform nonclassical transcription regulatory functions. Importantly, changes in the composition of the nucleus-localized pool of TnT3 and its fragments contribute to age-dependent muscle damage and wasting. Here, using ChIP-Seq, we demonstrate that TnT3 associates with DNA consensus sequences including the TGCCT motif, which is required for p53 binding to the promoter area of p53-related genes. Gene set enrichment analysis further demonstrated that the p53 pathway was the most significantly enriched pathway among genes annotated to the TnT3 ChIP-Seq peaks. We further demonstrated a strong correlation (r = 0.78, P = 1 × 10 −4 ) between the expression levels of TNNT3 and TP53-inducible ribonucleotide reductase regulatory subunit M2B (RRM2B) in skeletal muscle tissue of 21 lean non-diabetic human subjects and a significant (P < 0.05) reduction in the levels of both gene transcripts in the third agetertile group [42.3-70 years of age (yoa)] as compared to the second age-tertile (31.3-42.3 yoa). Of note, both TNNT3 and RRM2B expression levels negatively associated with total body fat mass (each with r = 0.49, P < 0.05), whereas RRM2B positively correlated with pancreatic β cell function (r RRM2B~HOMA-B = 0.47, P = 0.047). This work suggests that reduced TNNT3 gene expression is another mechanism leading to reduced TnT3 and excitation-contraction coupling with aging. Consequently, TnT3 appears to contribute to age-related sarcopenia and possibly other age-related deficiencies such as muscle insulin resistance and β cell dysfunction by interacting with TnT3-binding sequences in the promoter area of p53-related genes, among others, and consequently modulating the transcriptional regulation of these target genes.
Introduction
Tropomyosin (TM)-binding troponin (TnT) together with the calcium-binding troponin C (TnC) and the inhibitory subunit troponin I (TnI) form a complex that regulates muscle contraction. Specifically, the troponin complex interacts with actin and binds calcium to trigger production of muscle force (Gordon et al., 2000) . In addition to this classical cytoplasmic location and function, the fast skeletal muscle TnT3 shuttles to the nucleus (Zhang et al., 2013c) . As TnT3 exhibits a relaxed leucine zipper DNA-binding domain (Zhang et al., 2013a) , we hypothesized that TnT3 plays a nonclassical role in gene transcription regulation. (Latchman, 2008) TnI, TnT, Tm, and other cytoskeletal proteins shuttle to the nucleus in various cells. TnI has been reported in the nucleus of Drosophila nonmuscle cells (Sahota et al., 2009 ) and TnI and TnT in rat and human cardiomyocytes (Asumda and Chase, 2012; Bergmann et al., 2009) ; however, their function in these locations is largely unknown.
Consistently, we demonstrated that the nonmyofilament-associated fast skeletal muscle TnT3 enters the nucleus through a COOH-terminus nuclear localization sequence (NLS), KLKRQK (Zhang et al., 2013a; Zhang et al., 2013c) . We reported that, by engaging a functional leucine zipper domain conserved among species (Zhang et al., 2013b) , TnT3 directly binds to characteristic sequence motifs in the nuclear DNA and may, therefore, regulates gene transcription (a nonclassical role for this protein) and/or function in nuclear signaling . In addition, studies of TnT modulation of gene expression in human iPSCderived cardiomyocytes suggested that nucleus-translocated cardiac type TNNT2 may contribute to novel epigenetic mechanisms that underlie the pathogenesis of dilated cardiomyopathy (Wu et al., 2015) . Notably, TnI was also recently demonstrated to translocate to the nucleus and play a role in normal and tumor growth by transcriptionally upregulating the expression of several genes involved in cell proliferation (Casas-Tinto et al., 2016) . These reports therefore, support novel non-canonical nuclear roles for troponins in general.
Our previous work further revealed that nuclear TnT3 functions as a transcription factor, which may change over time since the nuclear TnT3 abundance and integrity changes with aging in a mouse model (Zhang et al., 2013c) . Whether TnT3 regulates genomic motifs for major transcription factors involved in cell senescence, cancer cell proliferation, and/or replication of mitochondrial DNA, is unknown. Using ChIP-sequencing (ChIP-Seq) in differentiated mouse muscle cells and quantitative expression profiling in biopsied human muscle tissue, the present study examines potential genes and pathway targets of nucleus-translocated TnT3.
Results

Genomic occupancy of TnT3
To understand how TnT3 regulate gene expression in muscle cells, we used ChIP-Seq to profile its genomic occupancy in C2C12 cells. Chromatin was immunoprecipitated from differentiated C2C12
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Consensus Score 1 TGCCTYAG 68.6 2 A H G T T N A G 6 7 . 5 3 GCAHHTTA 62.5 4 C A V A T C V A 6 1 . 6 5 C B S ND G G R AC A 6 0 . 5 6 C A T C H B A G T myotubes using a TnT3-specific antibody and compared to chromatin immuno-precipitated by a control IgG antibody. A QC report for the raw reads is presented in Supplementary Figure SF1 . TnT3 occupied 688 genomic sites with FDR≤0.1 (Fig. 1A , Supplementary Table ST1) , of which 111 were localized to the promoter region, 275 to introns, 32 to exons, 9 to the 3′-UTR, 2 to the 5′UTR, 5 to downstream regions up to 3 kb distant from the end of the 3′-UTR, and 254 were localized to distal intergenic sequences (Fig. 1B-C) . The binding sites in the promoter area tend to locate in 1 kb proximity of the transcription start sites (TSS) (Fig. 1D ).
De novo discovery of TnT3′s DNA binding motifs
Using the Bioconductor package BCRANK we conducted de novo discovery of DNA binding motifs in peak regions of the TnT3 ChIP-Seq experiment. The list of the top 25 motifs identified for TnT3 and the sequence logo for the top motif are presented in Fig. 1E-F . Notably, the top motif sequence TGCCT(CT)AG includes the sequence TGCCT, which is required for p53 binding to the promoter area of p53 related genes (Funk et al., 1992; Kern et al., 1991) .
Functional enrichment analysis
To find significant functional trends among the genes annotated in the ChIP peak regions identified by ChIP-Seq we used the R SetRank package. This package implements an advanced GSEA algorithm that eliminates many false positive hits, a common problem to functional enrichment tools based on gene sets compiled from gene and pathway annotation databases. Table 1 and Fig. 1G show the main results from the functional enrichment analysis of the significant ChiP-Seq peaks identified in our study. Notably, two categories related to p53 signaling were among the top five enriched categories as defined by the SetRank score (a value that reflects the prominence of a gene set in a gene set network and is calculated using the PageRank algorithm (Brin and Page, 1998) ). The mouse gene ribonucleotide reductase M2 B (TP53 inducible) (Rrm2b), one of the top genes significantly enriched for TnT3 binding (Supplementary Table ST1 ) was also detected among the key network genes at the intersection of the top SetRank nodes: the p53 signaling and the mitochondrial DNA replication nodes, among others (Supplementary Table ST2 ).
TNNT3 and RRM2B expression in human skeletal muscle
To assess the translational value of our in vitro studies using the mouse muscle cells and ChIP-Seq, we additionally profiled (by quantitative TaqMan RT-PCR) the expression of the human TNNT3 and RRM2B genes in the vastus lateralis muscle of 21 lean non-diabetic human subjects ( Fig. 2A-G) . The summary of clinical characteristics for this human cohort is presented in Table 2 . Gender and BMI had been a priori designated as potential confounders and therefore included as covariates in the linear models and the calculation of partial correlations. We demonstrated a strong correlation (r = 0.78, P = 1 × 10 −4 , Fig. 2D ) between the expression levels of TNNT3 and RRM2B in the skeletal muscle tissue of the human subjects and a significant (P < 0.05) downregulation of both gene transcripts in the third agetertile group [42.3-70 years of age (yoa)] as compared to the second age-tertile (31.3-42.3 yoa) ( Fig. 2A-C) . A similar but statistically nonsignificant trend was observed when comparing the third and first (23-31.3 yoa) age-tertile groups. In addition, human muscle levels of both TNNT3 and RRM2B transcripts significantly and negatively correlated with total body fat mass determined by DXA (r TNNT3~Fat Mass = −0.49, r RRM2B~Fat Mass = −0.49, both P < 0.05, Fig. 2E-F) . Of note, RRM2B transcript levels also significantly correlated with pancreatic β cell function (r RRM2B~HOMA-B = 0.47, P = 0.0473, Fig. 2G ), as estimated by the homeostatic model assessment (HOMA). The HOMA method is based on the physiological relationship between glucose and insulin in the basal (fasting) state, which reflects the balance between hepatic glucose output and insulin secretion that is maintained by feedback loops between the liver and the pancreas (Turner et al., 1979; Wallace et al., 2004) . Since its inception in 1985 (Matthews et al., 1985) , the HOMA model has proven useful for assessing pancreatic β cell function (HOMA-B) and insulin resistance (HOMA-IR) and is widely used in clinical and epidemiological studies.
Discussion
We have recently demonstrated that the fast skeletal muscle TnT3 isoform can translocate to the nuclei of mature myofibers and consequently induce muscle cell apoptosis in an age-dependent manner (Zhang et al., 2013a; Zhang et al., 2013c) . We further demonstrated that TnT3 contains bona fide nuclear and nucleolar localization signals and mediates binding to the DNA through a leucine zipper (LZD) Table constructed using the R package tableone. Data expressed as median and interquartile range inside square brackets. P values calculated using the nonparametric Kruskal-Wallis rank sum test. Square bracket symbols in age ranges indicate that the respective age limit is included; parenthesis indicates the limit is not included. Gender expressed as count and percentage inside parentheses. F: female, M: male.
domain to function as a transcription factor (Zhang et al., 2013a; Zhang et al., 2016) . These studies suggested a possible link between the deleterious effects of TnT3 overexpression and age-related sarcopenia.
In the current study, we identify genome-wide sequence motifs targeted by nuclear TnT3 in differentiated C2C12 muscle cells using ChIP-Seq analysis. Interestingly, the top motif identified [TGCCT(C/ T)AG] includes the sequence TGCCT, which is required for p53 binding to the promoter area of p53 related genes (Funk et al., 1992; Kern et al., 1991) . Supporting the potential binding of nuclear TnT3 to this particular ChIP-Seq motif, we previously clearly demonstrated that TnT3 directly binds a related sequence (i.e., ATCTGCC-AG, bold fonts denote the matching aligned consensus sequence) in the P5 promoter region of the calcium voltage-gated channel subunit alpha1 S (Cacna1s) gene . This previous work also showed that the effect of reduced/fragmented nuclear TnT3 leading to loss in muscle force, was rescued by in vivo treatment with an anti-calpain agent in old mice.
Further supporting our findings, functional enrichment analysis using an advanced GSEA algorithm highlights a p53 signaling-related subnetwork (Fig. 1E) including the top SetRank categories enriched among the annotated TnT3 ChIP-Seq peaks. We reason that the overlapping of TnT3 and p53 DNA binding motifs might cause interference (e.g., competition) between the two transcription factors, therefore negatively affecting each other regulatory functions at specific DNA loci under specific conditions. Remarkably, a negative association between peak serum troponin T levels and circulating Bnip3L (the transcription of which is driven by p53) has been recently reported in acute myocardial infarction patients (Pereg et al., 2015) . We speculate that TnT3 might differentially bind to TGCCT-related sequences in the promoter area of p53-regulated genes and consequently interfere with their p53-induced transcriptional activation and respective novel roles in cardioprotection [suggested by the work of (Pereg et al., 2015) and (Gogna et al., 2013) ]. Alternatively, and likely depending on genomic context, nucleus-translocated TnT3 might also contribute to activating the expression of specific p53-controlled genes in an p53-independent manner. Of note, the p53 pathway plays a crucial role at the intersection among longevity, cellular senescence, and tumor suppression.
The gene Rrm2b, encoding p53-controlled ribonucleotide reductase M2 B (also known as p53R2), identified in this study as a key TnT3-ChIP-Seq network gene at the intersection of the p53 signaling and the mitochondrial DNA replication nodes, has been reported to play a crucial role in dNTP supply for mitochondrial DNA (mtDNA) synthesis in both human and mouse. Mutations in this gene cause severe heritable mtDNA depletion in muscle of humans and similar effects are observed in the Rrm2b −/− mouse (Bourdon et al., 2007) . Through the production of dATP, the ribonucleotide reductase complex (of which the Rrm2b protein is a subunit) can also contribute to the enhancement of actomyosin function and muscle contractility . Consequently, genetic overexpression of the Rrm2b gene improved cardiac function in failing rodent hearts (Kolwicz Jr. et al., 2016; Korte et al., 2011; Nowakowski et al., 2013) . We reason that the TnT3-mediated transcriptional regulation of Rrm2b expression may therefore contribute, at least in part, to mtDNA maintenance defects and loss of muscle function in the elderly, with potential impact in the development of increased risk for cardiomyopathies.
Our validation experiments in a human cohort of lean people with age ranging from 23 to 70 yoa demonstrated a strong association between the expression levels of TNNT3 and RRM2B in the human skeletal muscle tissue and a significant reduction of both gene transcripts in the older age group. These results indirectly support the suggested transcriptional regulation of RRM2B by TnT3 in both mouse and humans, and underscore the role that these two molecules play during aging. Notably, the transcriptional regulation of RRM2B by TnT3 in skeletal muscle, their age-dependent expression levels, and the correlation between muscle RRM2B and pancreatic β cell function (HOMA-B) in humans, may provide mechanistic insight into the pathophysiology of insulin resistance of skeletal muscle and the progressive β cell dysfunction observed in mitochondrial diabetes (Lindroos et al., 2009; Szendroedi et al., 2009) . This relationship may also play a role in agerelated (late onset) diabetes, as sarcopenic muscle has been suggested to cause diabetes in aging populations (Cuthbertson et al., 2016; Lee et al., 2011; Scott et al., 2016) . The negative correlations between whole body fat mass and muscle TNNT3 and RRM2B (independent of gender and BMI) are also relevant and consistent with this hypotheses, as obesity and fat mass are associated with chronic inflammation and muscle/systemic insulin resistance (Kim et al., 2000; Kim and Park, 2018; Nicholas et al., 2016; Virtanen et al., 2005; Wellen and Hotamisligil, 2005) . By the same token, these associations may provide insights into pathophysiological mechanisms in sarcopenic obesity (Kim et al., 2013; Levine and Crimmins, 2012; Sakuma and Yamaguchi, 2013) .
In summary, we now identify the sequence motifs targeted by nuclear TnT3 in differentiated muscle C2C12 cells and uncover the transcriptional targeting of p53-related genes and pathways, including the negative regulation of apoptotic p53 signaling and the p53-controlled replication of mtDNA, as top candidate mechanism by which nuclear TnT3 might contribute to muscle dysfunction and sarcopenia. The validation, in a human cohort, of an age-dependent effect and a strong correlation between the expression levels of TNNT3 and its suggested transcriptional target p53-dependent RRM2B, as well as associations with total body fat mass and β cell function, enhances the translational value of our findings. However, our study has limitations that need to be addressed in future studies. Specifically, the direct binding of TnT3 isoforms to the consensus DNA motifs need to be demonstrated by gel shift assays, and the gene-specific transcriptional regulatory functions interrogated with luciferase reporter assays, among others. This study together with previously published work from our group set the stage for future work addressing the potential mechanistic involvement of TnT3 and RRM2B in the development of age-related sarcopenia, sarcopenic obesity, and the progressive β cell dysfunction observed in mitochondrial and late-onset diabetes.
Supplementary data to this article can be found online at https:// doi.org/10.1016/j.exger.2018.03.012.
